APA (7th ed.) Citation

Cherian Verghese, Weihong Li, Nanuli Gvazava, Emmanouil Alimpertis, Navkirat Kahlon, Hongliu Sun, & Robert Booth. (2022). IGH/BCL2 Status Better Predicts Clinico-Pathological Behavior in Primary Splenic Follicular Lymphoma than Histological Grade and Other Molecular Markers. SAGE Publishing.

Chicago Style (17th ed.) Citation

Cherian Verghese, Weihong Li, Nanuli Gvazava, Emmanouil Alimpertis, Navkirat Kahlon, Hongliu Sun, and Robert Booth. IGH/BCL2 Status Better Predicts Clinico-Pathological Behavior in Primary Splenic Follicular Lymphoma than Histological Grade and Other Molecular Markers. SAGE Publishing, 2022.

MLA (9th ed.) Citation

Cherian Verghese, et al. IGH/BCL2 Status Better Predicts Clinico-Pathological Behavior in Primary Splenic Follicular Lymphoma than Histological Grade and Other Molecular Markers. SAGE Publishing, 2022.